ADENOSINE THERAPEUTICS LLC has a total of 33 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and micro-structure and nano-technology are NSAB AF NEUROSEARCH SWEDEN AB, SANOFI AVENTIS SA and STOICESCU DAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | United States | 6 | |
#3 | China | 4 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | Brazil | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | New Zealand | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Thompson Robert D | 26 |
#2 | Rieger Jayson M | 25 |
#3 | Wang Guoquan | 12 |
#4 | Beauglehole Anthony | 6 |
#5 | Guoquan Wang | 4 |
#6 | Kranenburg Onno | 3 |
#7 | Borel Rinkes Inne | 3 |
#8 | Van Der Bilt Jarmila | 2 |
#9 | Jayson M Rieger | 1 |
#10 | Thakur Ajit B | 1 |
Publication | Filing date | Title |
---|---|---|
US2008262001A1 | Agonists of a2a adenosine receptors for treating recurrent tumor growth in the liver following resection | |
WO2008088816A1 | Adenosine derivative formulations for medical imaging | |
US2008125425A1 | Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B adenosine receptors | |
CN101516882A | Selective antagonists of A2A adenosine receptors | |
WO2006091896A2 | Pyridyl substituted xanthines | |
WO2006091898A2 | Pyrazolyl substituted xanthines | |
CN1972945A | Selective antagonists of A2A adenosine receptors |